ATP
ATP HYDROLYSI
ATPASE ACTIVITY
ATPASE ACTIVITY
ATPASE ACTIVITY
ATPASE ACTIVITY
ATPASE ACTIVITY
ATPASE ACTIVITY
MUSCLE MYOSINII ATPASE ACTIVITY
PLATELET NM-MYOSINII S1 FRAGMENT ATPASE ACTIVITY
ABDIL
ACANTHAMOEBA MYOSINIC
ACANTHAMOEBA MYOSINIC
ACANTHOMOEBA
ALEXA-DYE
ANTIBODY
ANTIBODY
APLYSIA BAG CELL NEURON
APLYSIA BAG CELL NEURON SYSTEM
APLYSIA SYSTEM
ARP COMPLEX
ARP-3 LOCALIZATION
ARP2
ARP2
ARP2
ARP2
ARP2
ARP2
ARP2
ARP2
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3 DE-LOCALIZATION
ARP3 IMMUNOFLUORESCENCE
ARP3 LOCALIZATION
ARP3 LOCALIZATION
ARP3 SIGNAL
ARP3 STAINING
ARP3-GFP
ARP3-GFP LOCALIZATION RETURN
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BDM ACTIVITY
BDM APPLICATION
BDM APPLICATION
BDM INHIBITION
BDM MEDIATED
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BS-C-1
BS-C-1 CELL
BS-C-1 CELL
BS-C-1 CELL
BOVINE SERUM           ALBUMIN
CALBIOCHEM
COMPOUND TREATMENT
IMMUNOFLUORESCENCE CELL COMPOUND TREATMENT
CONTROL CELL
COVERSLIP
COVERSLIP
COVERSLIP
CURRENT UNDERSTANDING
CYTOCHALASIN D
DIMETHYL SULFOXIDE
DIMETHYL SULFOXIDE
DMSO CONCENTRATION
DMSO TREATMENT
DE-LOCALIZATION
ACTIN LEADING EDGE COMPONENT DE-LOCALIZATION
DISCUSSION BDM
EGILE
EXPERIMENTAL APPROACH
FIGURE 1B(CELLS THAT SHOWED SIGNIFICANT PERTURBATION BY THE PERMEABILIZATION PROCESS DID NOT SHOW GREATER ACTIN INCORPORATION)
FILOPODIAL EXTENSION
FLUORESCENCE LEVEL
GFP-ARP3 GFP-ARP3 CELL
HAMMAMATSU-ORCAER
IMMUNOFLUORESCENCE CELL
LIEBOVITZ L-15 MEDIUM
LISTERIA
LISTERIA
LISTERIA
LISTERIA BACTERIUM
LISTERIA BACTERIUM
LISTERIA COMET TAIL
LISTERIA MONOCYTOGENE
LISTERIA MONOCYTOGENE
LISTERIA MOTILITY
LOCALIZATION
ML-7 TREATMENT
METAMORPH SOFTWARE
MGCL
MOLECULAR PROBE
NA OIL EMERSION PHASE OBJECTIVE
NIKON TE300
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PERMEABILIZED CELL
PERMEABILIZED CELL ASSAY
RL
REMAINING EXPERIMENTSWERE
RETROGRADE FLOW
S. CERVISEAE
S. CERVISEAE
SANTA CRUZ SC-8432
SIGMA
TB
TBS-TX
TBS-TX
TBS-TX
TBS-TX
TL
TM
TITRATION
BUTANEDIONE MONOXIME TITRATION
TRITON X-100
TRITONX-100
VASP
VASP
VASP
VASP
VASP
VASP
VCA-ACTIVATED ARP2
WASP/WAVE FAMILY
WAVE FUNCTION
WAVE1
WAVE1
WHATMAN PAPER
ABILITY
ABSENCE
ABSENCE
COMPOUND ABSENCE
MYOSIN ABSENCE
ABSORBANCE
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN ASSEMBLY
ACTIN CYTOSKELETAL RESEARCH
ACTIN CYTOSKELETON
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN FILAMENT FORMATION
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN LEADING EDGE
ACTIN LEADING EDGE COMPONENT
ACTIN MEDIATED PROCESS
ACTIN MONOMER
ACTIN NETWORK
ACTIN NETWORK
ACTIN NETWORK
ACTIN NUCLEATION
ACTIN NUCLEATION
ACTIN NUCLEATION
ACTIN NUCLEATION
ACTIN NUCLEATION ARP2
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION MACHINERY
ACTIN-DEPENDENT PROCESS
ACTIN-DEPENDENT PROCESS
ADDITION
AFFINITY
ANTIBIOTIC-FREE MEDIUM
ASPECT
ACTIN CYTOSKELETAL RESEARCH ASPECT
ASSAY
BIOLOGICAL PROCESS
BIOLOGICAL PROCESS
BIOLOGICAL PROCESS
BLEBBISTATIN
BLOCKED INCORPORATION
CAUSAL RELATIONSHIP
CELL MOTILITY
CENTRIPETAL FLOW
ACTIN CENTRIPETAL FLOW
CHICKEN MYOSINV
CHROMOPHORE ASSISTED LASER INACTIVATION
COATED COVERSLIP
COELOMYOCTE SYSTEM
COLLABORATION
COMPOUND
COMPOUND
COMPOUND
COMPOUND
CONCENTRATION
CONCENTRATION
CONTRACTION
ACTIN NETWORK CONTRACTION
CONTRIBUTION
COVERSLIP
CYTOSKELETAL NETWORK
CYTOSKELETON
CYTOSKELETON
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
ARP2 DE-LOCALIZATION
ARP3 DE-LOCALIZATION
LEADING EDGE COMPONENT DE-LOCALIZATION
DE-LOCALIZED
DE-LOCALIZED
DENDRITIC NETWORK
DESCRIPTION
DETERGENT SAPONIN
DILUTED CONCENTRATION
DISCREPANCY
DISSOCIATION
DISSOCIATION
DORSAL
DRUG TREATMENT
DYNAMIC SYSTEM
EDGE ACTIN NETWORK
EDGE ACTIVITY
EDGE COMPONENT
EDGE COMPONENT
ESTABLISHMENT
EXOGENOUS ACTIN
EXOGENOUS ACTIN
EXOGENOUS ACTIN
EXPRESSING ARP3-GFP
FETAL CALF SERUM
FILAMENT ELONGATION
FILAMENT FORMATION
FILAMENT NUCLEATION
FILOPODIA
FILOPODIA
FILOPODIA FORMATION
FILOPODIA-LIKE PROJECTION
FILOPODIAL EXTENSION
FILOPODIAL PRECURSOR
FINAL MANUSCRIPT
FIXED
FIXED
FIXED
FIXED
FLOW CHAMBER
FLOW RATE
FLOW STUDY
FLUORESCENCE INCORPORATION
FLUORESCENCE INTENSITY
FLUORESCENCE LEVEL
FLUORESCENCE SIGNAL
FLUORESCENTLY LABELED ACTIN
FORMALDEHYDE
FORMALDEHYDE
G/ML
SAPONIN G/ML
GANGLIA NEURON
GLYCEROL
GOAT ANTI-MOUSE
GOAT ANTI-RABBIT
GROWING END
GROWING END
ACTIN FILAMENT GROWING END
ACTIN FILAMENT GROWING END
GROWTH
GROWTH
GROWTH CONE INTERIOR
HEAT BLOCK
HR
HR
HR
IMMUNOFLUORESCENCE CELL
INCORPORATION
INCORPORATION
INCORPORATION
EXOGENOUS ACTIN INCORPORATION
EXOGENOUS ACTIN INCORPORATION
INTERACTION
INTERPRETATION
JASPLAKINOLIDE
JASPLAKINOLIDE
LEADING EDGE COMPONENT
LEADING EDGE COMPONENT
LEADING EDGE COMPONENT
LEADING EDGE COMPONENT
LEADING EDGE LOCALIZATION
LINESCAN
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION EQUIVALENT
ARP3 LOCALIZATION
ARP3 LOCALIZATION
ARP3 LOCALIZATION
VASP LOCALIZATION
LEADING EDGE COMPONENT LOCALIZATION
MM ATP
MM BDM
MM BDM
MM BDM
MM BDM
MM BDM
MM BDM
MM DTT
MM EGTA
MM ETGA
MM HEPE
MM K-PIPES PH
MM KCL
MM MGCL2
MM TRIS-PH
MM UREA
MAMMALIAN CELL
MAMMALIAN CELL
BUTANEDIONE MONOXIME MAMMALIAN CELL
MICROSCOPE
MILLIMOLAR INHIBITOR
MILLIMOLAR RANGE
MIN
MIN
MIN
MIN
MIN EPPENDORF CENTRIFUGE SPIN
BDM TREATMENT MIN
ML
MM PLL
COATED COVERSLIP MM PLL
MM POLY-L-LYSINE
MM ROUND PLL COVERSLIP
MOLECULE
MOLECULE
MOLECULE APPROACH
MORPHOLOGICAL CHANGE
MOTOR PROTEIN
MOUSE ACTIN ANTIBODY
M
MUSCLE MYOSINII
MYOIE
MYOIE
MYOSIN
MYOSIN ATPASE EXPERIMENT
MYOSIN S1 MICROINJECTION
MYOSIN ACTIVITY
MYOSIN ACTIVITY
MYOSIN FUNCTION
MYOSIN MOTOR PROTEIN
MYOSIN TARGET
MYOSIN
MYOSIN
PULLING FILAMENT MYOSIN
MYSOSIN
NM
NEGATIVE NM-MYOSINII
NEUTRAL DENSITY
NM
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
ATPASE ACTIVITY NM-MYOSINII
NM-MYOSINII FUNCTION
NM-MYOSIN
NON-MUSCLE MYOSINII
NON-MUSCLE MYOSINII
NON-MUSCLE MYOSIN
NON-MUSCLE MYOSIN
NUCLEATION
NUCLEATION
NUCLEATION ACTIVITY
ARP2 NUCLEATION ACTIVITY
NUCLEATION COMPLEX
ONE-MINUTE TREATMENT
ORGANIZATION
OSMOTIC EFFECT
BDM TREATMENT OSMOTIC EFFECT
P-PHENYLENEDIAMINE
PH
PEPTIDE
PERMEABILIZATION
PERMEABILIZATION
PERMEABILIZATION BUFFER
PERMEABILIZATION PROCESS
PERMEABILIZATION/FIXATION BUFFER
PERMEABILIZED CELL ASSAY
PERMEABILIZED CELL
PERMEABILIZED YEAST
PERSONAL COMMUNICATION
PERTURBATION
PLATELET NM-MYOSINII
PLATELET NM-MYOSINII S1 FRAGMENT
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION ASSAY
ACTIN POLYMERIZATION
PORCINE MYOSINVI
PROCESS INHIBITED
PROTEASE INHIBITOR
PROTEIN
PULLING FILAMENT
PUSH-PULL
PYRENE-ACTIN
POLYMERIZATION ASSAY PYRENE-ACTIN
RABBIT ARP3 ANTIBODY
RABBIT VASP ANTIBODY
RABBIT WAVE1 ANTIBODY
RABBIT MUSCLE MYOSINII
READOUT
RELATIONSHIP
ACTIN DYNAMIC RELATIONSHIP
REORGANIZATION
DENDRITIC NETWORK REORGANIZATION
RESUSPENDING
ROOM TEMP
SAMPLE SOLUTION
SAPONIN
SEA URCHIN COELOMOCYTE
SEA URCHIN COELOMOCYTE
SECONDARY ANTIBODY
SECONDARY ANTIBODY
SENSITIVE STRUCTURE
SHOWED LOCALIZATION
ARP3 SHOWED LOCALIZATION
STOCK SOLUTION
SUBUNIT
ACTIN NUCLEATION ARP2 SUBUNIT
TEMPORAL CONTROL
FILAMENT NUCLEATION TEMPORAL CONTROL
TEMPORARY INHIBITION
TIME-LAPSE EXPERIMENT
TIME-LAPSE MICROSCOPY
UM
UM BLEBBISTATIN
UM CYTOCHALASIN
UM CYTOCHALASIN
UM RHODAMINE ACTIN
UG/ML GENTAMICIN
UL
UL
LISTERIA UL
UN-DESCRIBED EFFECT
BDM TREATMENT UN-DESCRIBED EFFECT
UNDERSTANDING CELL
BIOLOGICAL PROCESS UNDERSTANDING CELL
WELL PLATE
WELL PLATE
WICKING
BUTANEDIONE MONOXIME
BDM
PURINE NUCLEOSIDE PHOSPHORYLASE
PNP
MYOSINIC
MYOSINIC
BAG CELL NEURON
CELL NEURON
APLYSIA BAG CELL NEURON
APLYSIA
neurons
LOCALIZATION
ARP3
DE-LOCALIZATION
ARP3
immunofluorescence
ARP3
LOCALIZATION
ARP3
LOCALIZATION
signals
ARP3
ARP3-GFP LOCALIZATION
applications
applications
inhibition
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
CONTROL
UNDERSTANDING
CYTOCHALASIN
CONCENTRATION
treatments
BDM
extensions
IMMUNOFLUORESCENCE
LISTERIA
LISTERIA
LISTERIA
LISTERIA
LISTERIA
motility
treatments
OIL EMERSION PHASE OBJECTIVE
EMERSION PHASE OBJECTIVE
TE300
PERMEABILIZED CELL
EXPERIMENTSWERE
FLOW
CERVISEAE
CERVISEAE
TRITON
ARP2
functions
papers
assemblies
CYTOSKELETAL RESEARCH
CYTOSKELETON
ACTIN FILAMENT
FILAMENT FORMATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
LEADING EDGE
ACTIN LEADING EDGE
NUCLEATION
NUCLEATION
NUCLEATION
NUCLEATION
ACTIN NUCLEATION
NUCLEATION ARP2
NUCLEATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION MACHINERY
ACTIN-DEPENDENT
ACTIN-DEPENDENT
INCORPORATION
RELATIONSHIP
motility
FLOW
MYOSINV
ASSISTED LASER INACTIVATION
LASER INACTIVATION
detergent
SAPONIN
drugs
treatments
edges
ACTIN
edges
edges
edges
ACTIN
ACTIN
ACTIN
ELONGATION
FORMATION
NUCLEATION
FORMATION
FILOPODIA-LIKE
extensions
FLOW
FLOW
FLOW
INCORPORATION
signals
LABELED ACTIN
anti-mouse
anti-rabbit
GROWTH
LEADING EDGE
LEADING EDGE
LEADING EDGE
LEADING EDGE
LEADING EDGE
edge localization
LOCALIZATION
ATP
BDM
BDM
BDM
BDM
BDM
BDM
DTT
EGTA
ETGA
KCL
MGCL2
urea
mammalian
mammalian
inhibitors
ranges
MIN
PLL
MM ROUND PLL
PLL
approaches
changes
MOUSE ACTIN
ACTIN
MYOSINII
MYOSIN
S1 MICROINJECTION
S1
functions
MYOSIN MOTOR
targets
functions
NON-MUSCLE
MYOSINII
NON-MUSCLE
MYOSINII
NON-MUSCLE
NON-MUSCLE
treatments
buffer
buffer
PERMEABILIZED CELL
communication
PLATELET NM-MYOSINII
S1
MYOSINVI
proteases
RABBIT ARP3
ARP3
RABBIT VASP
VASP
RABBIT WAVE1
WAVE1
MUSCLE MYOSINII
solution
SEA
URCHIN COELOMOCYTE
SEA
LOCALIZATION
stocks
solution
CONTROL
inhibition
EXPERIMENTS
UM
BLEBBISTATIN
UM
UM
RHODAMINE ACTIN
ug/ml
GENTAMICIN
effects
wells
wells
